Reports (21)

  • Blood-Brain Barrier, Central Nervous System Agents, pharmacology, Drug Delivery Systems, Drug Design, Nervous System Diseases, drug therapy ,
    Optimizing investments in Belarus' Tuberculosis Response

    . Optima Consortium of Decision Sciences

    Get Access
  • Biomarkers, Pharmacological , Central Nervous System Diseases, diagnosis , Central Nervous System, drug effects, Drug Discovery, Glutamic Acid, adverse effects, Neuropharmacology, methods,
    NHS top managers, knowledge exchange and leadership: the early development of Academic Health Science Networks – a mixed-methods study

    E Ferlie

    Get Access
  • Endocrine Glands, drug effects , Environmental Exposure, Environmental Pollutants, pharmacology, Hormones, physiology,
    Report on the Bartlett Research Exchange on Health and Wellbeing in the Built Environment: An interdisciplinary perspective on health and wellbeing in the built environment

    LS Vaughan

    Get Access
  • Biomarkers, Environmental Exposure, adverse effects, Neoplasms, etiology, Nicotine, pharmacology, Smoke, adverse effects, Tobacco Smoke Pollution, prevention & control ,
    Children of the new century: mental health findings from the Millennium Cohort Study

    LM Gutman

    Get Access
  • Antibodies, Monoclonal, isolation & purification , Drug Industry, Technology, Pharmaceutical, methods, United States, Vaccines, chemical synthesis, Vaccines, isolation & purification,
    Personal Habits and Indoor Combustions.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Access to Information, Clinical Trials as Topic , Information Dissemination, International Cooperation, Pharmaceutical Preparations ,
    Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Africa South of the Sahara, Health Services Accessibility, Medically Underserved Area, Mental Disorders drug therapy, Nervous System Diseases drug therapy, Pharmaceutical Preparations supply & distribution, Substance-Related Disorders drug therapy
    Printing Processes and Printing Inks, Carbon Black and Some Nitro Compounds.

    IARC Working Group on the Evaluation of Carcinogenic Risk to Humans

    Get Access
  • Formularies as Topic , Pharmaceutical Services, organization & administration, Quality of Health Care, United States, Veterans ,
    Evaluating Obesity Prevention Efforts: A Plan for Measuring Progress.

    National Academies Press (US)

    Get Access
  • Drug Discovery, methods, Drug Repositioning , Pharmaceutical Preparations, economics, United States,
    The National Cancer Policy Summit: Opportunities and Challenges in Cancer Research and Care

    Institute of Medicine (US) National Cancer Policy Forum

    Get Access
  • Drug Design, Drug Evaluation standards, Internationality, Legislation, Drug, Pharmaceutical Preparations supply & distribution
    The National Children's Study 2014: An Assessment

    National Academies Press (US)

    Get Access
  • Age Factors, Child, Drug Therapy, Infant, Legislation, Drug, Pharmacokinetics
    The National Children's Study Research Plan: A Review

    National Research Council (US) and Institute of Medicine (US) Panel to Review the National Children's Study Research Plan

    Get Access
  • Disaster Planning organization & administration, Disasters, Emergencies, Medication Systems organization & administration, Pharmaceutical Preparations supply & distribution, Strategic Stockpile, United States
    Toxicologic Assessment of Jet-Propulsion Fuel 8

    National Research Council (US) Subcommittee on Jet-Propulsion Fuel 8

    Get Access
  • Covid-19, medical manufacturing, Africa, pharmaceutical industry
    Toxicological Effects of Methylmercury

    National Research Council (US) Committee on the Toxicological Effects of Methylmercury

    Get Access
  • COVID-19, Africa, pharmaceutical manufacturing
    Toxicological Risks of Selected Flame-Retardant Chemicals

    National Research Council (US) Subcommittee on Flame-Retardant Chemicals

    Get Access
  • Pharmacy, Workforce, Global, Workforce Intelligence
    Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary

    Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation

    Get Access
  • Pharmacy workforce, Global, Workforce, Research and development, Workforce impact, Pharmacy
    Transforming Health Care Scheduling and Access: Getting to Now

    National Academies Press (US)

    Get Access
  • Pharmacy workforce, International, Transforming, WDG, workforce development, Development
    Coronavirus Act (2020) Two Years On - written evidence submitted to the Public Administration and Constitutional Affairs Committee call

    C O'Donovan

    Get Access
  • Pharmacy, vaccination, immunisation, global
    Learning through Disruption: Using schools' experiences of Covid to build a more resilient education system

    G Moss

    Get Access
  • Pharmacy workforce, interprofessional, education, Global
    Response from the UK Pandemic Ethics Accelerator to the Joint Science and Technology and Health Select Committee inquiry: Coronavirus: Lessons learnt

    C O'Donovan

    Get Access
  • Pharmacy, workforce, global
    Making older people visible: solving the denominator problem in care home data

    C O'Donovan

    Get Access
  • Pharmacy, professional recognition, Advanced practice, Credentialing
    Immunity certification infrastructures and ethics: Principles and strategies for decision making

    C O'Donovan

    Get Access

Your Feedback